Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England.

Kilcoyne, Adrian; Jordan, Edward; Thomas, Kimberly; Pepper, Alicia N; Zhou, Allen; Chappell, Dale; Amarapala, Miyuru; Thériault, Rachel-Karson; Thompson, Melissa

Kilcoyne, Adrian; Jordan, Edward; Thomas, Kimberly; Pepper, Alicia N; Zhou, Allen; Chappell, Dale; Amarapala, Miyuru; Thériault, Rachel-Karson; Thompson, Melissa.

Afiliación

Kilcoyne A; HEOR, Humanigen Inc, Burlingame, CA, USA.
Jordan E; HEOR, Humanigen Inc, Burlingame, CA, USA.
Thomas K; Value & Evidence Services, EVERSANA, Burlington, Ontario, Canada.
Pepper AN; Value & Evidence Services, EVERSANA, Burlington, Ontario, Canada.
Zhou A; Value & Evidence Services, EVERSANA, Burlington, Ontario, Canada.
Chappell D; HEOR, Humanigen Inc, Burlingame, CA, USA.
Amarapala M; HEOR, Humanigen Inc, Burlingame, CA, USA.
Thériault RK; Value & Evidence Services, EVERSANA, Burlington, Ontario, Canada.
Thompson M; Value & Evidence Services, EVERSANA, Burlington, Ontario, Canada.

Clinicoecon Outcomes Res ; 14: 231-247, 2022.

Article en En | MEDLINE | ID: mdl-35444434

Palabras clave

CRP; GM-CSF; economic analysis; invasive mechanical ventilation; survival without ventilation; ventilator-free survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Clinicoecon Outcomes Res Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google